mmu-mir-1946a: Mmu-mir-1946a is a type of microRNA that has been implicated in various diseases, including platelet disorder, familial, associated myeloid malignancy and leukemia, and acute myeloid [27-29]. It is one of the key miRNAs that may have a role in neurological disorders such as amyotrophic lateral sclerosis, attention-deficit hyperactivity disorder (ADHD), and bipolar disorder [30-34]. Dopamine, a neurotransmitter involved in signal transmission between nerve cells, interacts with dopamine receptors [PMC8874170]. Mmu-mir-1946a has been identified as one of the top significant miRNAs in various studies [PMC8874170]. It has been found to be upregulated in TC-1 cells and may be involved in the regulation of MMP-9 and TIMP-1 [PMC8986370]. Mmu-mir-1946a is predicted to bind to the 3' UTR of transforming growth factor (TGF-β1) in mouse lung fibroblasts, inhibiting its transcription [PMC8986370]. The expression of mmu-mir-1946a has been shown to be upregulated in BIPF (bleomycin-induced pulmonary fibrosis) and may play a regulatory role in this condition [PMC8986370]. Mmu-mir-1946a has also been found to interact with serpina3n, a potential target gene that is upregulated in BIPF [PMC8986370]. Additionally, mmu-mir-1946a has been shown to target several genes involved in fibrosis progression following BIPF [PMC8986370]. Further studies are needed to confirm the specific regulatory mechanisms of mmu-mir-1946a and its potential as a therapeutic target for diseases such as BIPF [PMC8986370][PMC9230989].